Tender Details

Country: USA
Summary: Antisense Oligonucleotide (ASO) Walk
UST Ref No: 125362238
Deadline: 12 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 75N95025Q00265
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
NOTICE OF INTENT to Sole Source
1. SOLICITATION NUMBER: 75N95025Q00265
2. TITLE: Integrated DNA Technologies (IDT) Antisense Oligonucleotide (ASO) Walk
3. CLASSIFICATION CODE:
6640 - LABORATORY EQUIPMENT AND SUPPLIES
NAICS CODE: 325413 - in-vitro diagnostic substance manufacturing
4. RESPONSE DATE:
September 12, 2025, at 11:59 PM EDT
5. PRIMARY POINT OF CONTACT:
Tiffany Stone
tiffany.stone@nih.gov
Phone: 301.480.7158
6. DESCRIPTION:
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) National Institute on Aging (NIA) intends to negotiate on a sole source basis with Integrated DNA Technologies, Inc. to procure antisense oligonuceotides (ASOs) to perform cell-based experiments to identify which of them alter the level of expression of the target gene. IDT DNA Technologies is the established supplier for the ongoing ASO program. Using the same production platform preserves assay comparability, reduces variability, and accelerates translation to animal and pre-clicincal studies. IDT DNA Technologies, Inc can reproduce the exact MOE-gapmer chemistry with identical QC documentation, thereby risking batch effects and schedule delays. IDT offers the only combination of technical compatibility, documented performance, and cost efficiency that meet the project requirements.
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS
The intended procurement is classified under NAICS code 325413 - in-vitro diagnostic substance manufacturing with a Size Standard of $1,250.
REGULATORY AUTHORITY
This acquisition is for a commercial item or service and is conducted under the authority of the FAR Subpart 13.5—Simplified Procedures for Certain Commercial Products and Commercial Services, U.S.C 41 §1901 Simplif...
Documents:

Nugent_PurchaseDescription_36-ChannelOPMSystem-202.pdf

If you are registered member, kindly login to view full details of this tender notice:

Antisense Oligonucleotide (ASO) Walk - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Antisense Oligonucleotide (ASO) Walk. This tender is published on USARFP under UST Ref No: 125362238 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-12.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.